Concepedia
Statistics
Publications
14
Citations
365
H-Index
13
Active since
2010
Affiliations
Novartis (United States)(Current)
HealthInsight
Optum (United States)
Novartis (Switzerland)
Pharmerit (United States)
Satyin Kaura is an author at Novartis (United States) specializing in medicine, oncology, and breast cancer.
Top concepts
MedicineOncologySurgeryOsteoporosisBreast CancerCancer TherapyRadiation OncologyFinanceBusinessEconomics
Publications per year
2010–2016
Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective
George Dranitsaris, Bo Yu, Leiping Wang et al. · Journal of Oncology Pharmacy Practice · 2014 · 48 citations
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A cost-effectiveness analysis
Sonya J. Snedecor, John A. Carter, Satyin Kaura et al. · Journal of Medical Economics · 2012 · 46 citations · Full text
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
George Dranitsaris, Jennifer King, Satyin Kaura et al. · ClinicoEconomics and Outcomes Research · 2015 · 42 citations · Full text
Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007–18
Victoria Divino, Mitch DeKoven, Michael Kleinrock et al. · Health Affairs · 2016 · 38 citations · Full text
European Union Pharmaceutical Markets: A Case for Differential Pricing?
Adrian Towse, Michele Pistollato, Jorge Mestre-Ferrándiz et al. · International Journal of the Economics of Business · 2015 · 36 citations · Full text
Economics, Dynamic Pricing, Health Economics +14
1–5 of 14